Effect of Demeclocycline on Renal Function and Urinary Prostaglandin E2 and Kallikrein in Hyponatremic Cirrhotics
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 36 (1) , 30-37
- https://doi.org/10.1159/000183112
Abstract
Eight cirrhotics with hyponatremia were given demeclocycline (DMC) 900 mg/day to investigate its effect on renal function, plasma renin activity, aldosterone and urinary excretion of prostaglandin E2 and kallikrein. In 7 patients DMC induced an increase of free water clearance (from -0.36 .+-. 0.06 to 0.13 .+-. 0.06 ml/min) and serum Na concentration (from 125.4 .+-. 0.09 to 131.1 .+-. 1.0 meq/l, mmol/l). In 5 of these patients DMC also induced a marked reduction of glomerular filtration rate (from 72.2 .+-. 6.2 to 31,2 .+-. 4.7 ml/min) and renal plasma flow (from 468 .+-. 98 to 195 .+-. 55 ml/min) which could not be explained on the basis of hypovolemia. In each case this renal impairment was not associated with changes in urinary concentration of .beta.2-microglobulin, urinary cast excretion, fresh urine sediment or urine protein content and disappeared after discontinuation of the drug. DMC induced a marked increase in the urinary excretion of prostaglandin E2 (from 0.82 .+-. 0.27 to 6.16 .+-. 1.91 ng/min) in 6 out of the 7 patients who responded to DMC and a marked reduction in urinary kallikrein (from 16.1 .+-. 4.4 to 4.2 .+-. 1.6 pkat/min) in the 5 patients who developed renal insufficiency. The serum DMC concentration was > 5 .mu.g/ml in all patients who responded to DMC, > 8 .mu.g/ml in all cases who developed renal insufficiency and of 3 .mu.g/ml in the case not responding to DMC. DMC is an effective therapy for water retention and dilutional hyponatremia in cirrhosis but it produces renal insufficiency associated with an impairment of renal perfusion and with a reduced urinary kallikrein activity in a high proportion of patients. The inhibitory effect of DMC on water reabsorption in these patients may be due, at least in part, to an increased renal synthesis of prostaglandin E2 induced by the drug. A close relationship exists between the renal effects and the serum levels of DMC in cirrhosis.This publication has 19 references indexed in Scilit:
- Role of Vasopressin in Abnormal Water Excretion in Cirrhotic PatientsAnnals of Internal Medicine, 1982
- Renal Failure Associated with Demeclocycline in CirrhosisAnnals of Internal Medicine, 1977
- Demeclocycline Treatment of Water Retention in CirrhosisAnnals of Internal Medicine, 1976
- Prognostic value of spontaneous hyponatremia in cirrhosis with ascitesDigestive Diseases and Sciences, 1976
- Demeclocycline Treatment in the Syndrome of Inappropriate Antidiuretic Hormone SecretionAnnals of Internal Medicine, 1975
- Demeclocycline-Induced Nephrogenic Diabetes InsipidusAnnals of Internal Medicine, 1973
- Renal failure in patients with cirrhosis of the liverThe American Journal of Medicine, 1965
- Single Daily Dose Treatment of Psychiatric Patients with Phenothiazine DerivativesJournal of Mental Science, 1961
- DemethylchlortetracyclineNew England Journal of Medicine, 1958
- A RAPID METHOD FOR THE DETERMINATION OF PARA-AMINOHIPPURIC ACID IN KIDNEY FUNCTION TESTS1951